Sector News

Evonik launches sales process for both MMA and PMMA business

July 12, 2018
Chemical Value Chain

Evonik Industries has confirmed to CW that it has launched the sales process for its methyl methacrylates (MMA) and polymethyl methacrylate (PMMA) business.

The business operates 18 production sites. Barclays is advising on the divestment. Evonik hopes that by the end of the year it will have a clear idea as to who is interested, and perhaps a potential buyer. Information packages have been sent to both strategic buyers and private equity firms over the last few days, the company tells CW.

Evonik is the world’s second-largest producer of both MMA and PMMA. Its MMA capacity is about 600,000 metric tons/year and that of PMMA, sold under the Plexiglas trademark, about 400,000 metric tons/year. The MMA plants are located at Wesseling and Worms, Germany; Fortier, Louisiana; and Shanghai, China.

The company declined to comment on reports on Reuters that the business has annual sales of roughly €1.8 billion ($2.1 billion) and EBITDA of about €400 million, but sources tell CW that the business is very cyclical and that the revenue number for the combined operation, including MMA and PMMA, can vary between €1.5 billion and €1.8 billion. The company also says it is too early to say how much the business could fetch and that the number will depend on the scope that the potential buyer would be interested to include.

Evonik said last year that it was working to develop an ethylene-based process called LiMA to produce MMA. The technology is included in the divestment package. Prior to that, it developed a new MMA production process called Aveneer, which the company never commercialized. The Aveneer process is based on ammonia, methane, acetone, and methanol.

By Natasha Alperowicz

Source: Chemical Week

comments closed

Related News

December 3, 2022

Corteva to acquire Stoller Group for $1.2 billion

Chemical Value Chain

Corteva (Indianapolis, Indiana) says it has signed a definitive agreement to acquire Stoller Group (Houston, Texas), a producer of biostimulants and plant nutrition products, for $1.2 billion. Stoller is one of the largest independent biologicals companies globally, with operations in more than 60 countries and more than $400 million in annual sales.

December 3, 2022

OMV introduces new corporate structure to drive sustainable growth and innovation

Chemical Value Chain

OMV has announced its new corporate structure today, designed to fully enable the delivery of Strategy 2030. The new organization will be built on five distinct areas. In addition to the CEO and CFO areas, three business segments will be established: Chemicals & Materials, Fuels & Feedstock, and Energy.

December 3, 2022

What does the current downturn in industrial manufacturing mean for executives searching for a senior role in the chemicals industry?

Chemical Value Chain

The European petchem sector is readying for some tough quarters. It’s a different picture in the US. So is this the best time ever to find a new role in the chemical industry? If you are in Europe, you would expect me to say probably not. But actually, it depends. So let me give you four answers to this question.